Chemxpert Database
Share
Chemxpert Database is world's best Buyer & Supplier information platform for entire life science ind.
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 4 | 22nd August 2026 🚨
Zydus Gets FDA Nod | Revance & Teoxane Win Approval for Undereye Hollowing Treatment
🔹 Zydus receives final approval from USFDA for ascorbic acid injection
🔹 Revance and Teoxane announce the US FDA approval of RHA Redensity Eye for undereye hollowing
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 4 | 21st August 2026 🚨
Lupin Partners Tenpoint | Mankind Pharma Signs China Licensing Deal | Piramal Acquires Yapan Bio
🔹 Lupin partners with Tenpoint Therapeutics to commercialize Yuvezzi
🔹 Mankind Pharma enters into in-licensing agreement with Chongqing Chenan Biopharma
🔹 Piramal Pharma completes acquisition of controlling stake in Yapan Bio
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 4 | 20th August 2026 🚨
BioMarin Acquires Alesta for ALE1 | LEO Pharma Buys Dersimelagon Rights | Glenmark Wins FDA Nod
🔹 BioMarin to buy Alesta Therapeutics to gain ALE1, a potential first oral therapy for hypophosphatasia
🔹 LEO Pharma enters agreement to acquire worldwide rights to dersimelagon from Tanabe Pharma
🔹 Glenmark Pharma Gets US FDA Approval For Fluticasone Nasal Spray In $295 Million Market
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 4 | 19th August 2026 🚨
Hearzap Acquires Amplifon India | Acurx Gets FDA & USPTO Wins | OmniAb Partners Lilly
🔹 Hearzap completes acquisition of Amplifon India's hearing healthcare business
🔹 Acurx Pharma receives US FDA conditional acceptance and USPTO trademark allowance for company's brand name for Ibezapolstat
🔹 OmniAb enters global collaboration and license agreement for ion channel programme with Eli Lilly
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
19/08/2026
Top 10 Medical Organic Chemical Manufacturers by Market Capitalization 📊
Which companies are leading the medical organic chemicals landscape by market capitalization?
Our latest snapshot highlights Wanhua Chemical, Dow, LyondellBasell, Mitsubishi Chemical Group, Westlake, Eastman Chemical, Mitsui Chemicals, Arkema, Celanese, and Sumitomo Chemical.
Market capitalization provides an important view of how publicly traded companies are valued by the market—but it is only one part of understanding the competitive landscape.
For pharma, chemical, procurement, and business-development professionals, tracking chemical market trends, company valuations, manufacturing capabilities, competitive intelligence, and industry performance can support better strategic decisions.
📌 Save this post for your market research and share it with your network.
💬 Which company do you think has the strongest growth potential in the chemical industry?
🌐 www.chemxpert.com
📧 [email protected]
📞 9990237670
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 4 | 18th August 2026 🚨
Lupin Gets FDA Approval | Optimus Pharma Wins DCGI Nod | Slingshot Bio Unveils ViaComp
🔹 Optimus Pharma receives DCGI approval for Tapinarof Cream
🔹 Lupin receives US FDA approval for pitolisant tablets
🔹 Slingshot Bio Launches ViaComp® Ultra Amine: A Next-Generation Cell Mimic for Amine-Reactive Viability and Antibody Compensation in Multiparameter Flow Cytometry
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 3 | 13th August 2026 🚨
Alamar Teams with Gates Ventures | PTC Buys Fabry Program | Sentynl Licensing Deal
🔹 Alamar Biosciences expands global partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
🔹 Sentynl Therapeutics enters into license agreement with Mereo BioPharma for alvelestat for AATD-LD
🔹 PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
🚨 BREAKING IN PHARMA & BIOTECH | WEEK 11 | 11th August 2026 🚨
Redcliffe Labs Acquires Megavision | LifeCell Expands in Gujarat | Zydus Launches Revahale
🔹 Redcliffe Labs announces acquisition of Megavision Diagnostics
🔹 LifeCell International partners with Shraddha Diagnostics to expand access to diagnostic services across Gujarat
🔹 Zydus Lifesciences launches Revahale, India’s first once-daily nebulised LAMA for COPD
📈 From strategic collaborations to regulatory breakthroughs, the pharma ecosystem continues to evolve at an unprecedented pace.
🎯 Stay ahead with verified pharmaceutical intelligence, market trends, pipeline movements, clinical updates, and real-time biotech news — only on Chemxpert Database.
🎥 Watch complete coverage, market impact analysis & expert insights on our YouTube channel:
👉 https://www.youtube.com//videos
📰 Explore more pharma & biotech updates here:
👉 https://chemxpert.com/all-news
📊 Looking for deeper pharma intelligence, competitor benchmarking, company profiling, or market research insights?
📅 Book a demo with Chemxpert Database today:
👉 https://chemxpert.com/demo-request
🌐 Visit: www.chemxpert.com
📞 Toll-Free: 1800 4190 155
08/08/2026
The medical imaging chemicals and radiopharmaceuticals market is shaped by companies that are not only major industry players but also led by executives driving innovation across diagnostic imaging, contrast media, radiopharmaceuticals, and nuclear medicine.
Top 10 Medical Imaging Chemicals Companies by Market Capitalization (USD Billion)
• GE HealthCare — Peter J Arduini (President & CEO)
• Fujifilm Group — Teiichi Goto (President & CEO)
• Curium Pharma — Renaud. Dehareng (Group CEO)
• Lantheus — Mary Anne Heino (Executive Chairperson & Interim CEO)
• Jubilant Radiopharma — Harsher Singh (CEO)
• Bracco Imaging — Fulvio Renoldi Bracco (CEO)
• Beijing Beilu Pharmaceutical Co., Ltd. — Xu Wang (CEO)
• Guerbet — Karim Boussebaa (CEO)
• Voyageur Pharmaceuticals Ltd. — Brent Willis B.sc.Eng (CEO)
• Radiopharm Theranostics — Riccardo Canevari (Managing Director & CEO)
These companies continue to influence the development of medical imaging, contrast agents, radiopharmaceuticals, and theranostics. Tracking market capitalization alongside executive leadership provides valuable insight into the competitive landscape and future direction of the medical imaging industry.
Explore more chemical, pharmaceutical, and life-sciences market intelligence with Chemxpert Database.
🌐 www.chemxpert.com
📧 [email protected]
📞 +91 9990237670
🚨 Pharmaceutical & Biotech Industry Updates
Today's industry highlights showcase important developments in drug safety, sterile API manufacturing, and biotech innovation that continue to shape the global pharmaceutical landscape.
🔹 Fresenius Kabi has voluntarily recalled one lot of Morphine Sulfate Injection USP, Simplist® prefilled syringes due to a labeling mix-up. The action underscores the critical importance of FDA compliance, product quality, patient safety, and pharmacovigilance in pharmaceutical manufacturing.
🔹 Gland Pharma and Neuland Laboratories have announced a strategic collaboration focused on sterile API manufacturing, strengthening capabilities in high-quality pharmaceutical production and supporting the growing demand for advanced injectable therapies.
🔹 Mediar Therapeutics has entered into a Collaboration and Option Agreement with Ono Pharmaceutical to develop novel treatments for fibro-inflammatory diseases, reinforcing continued investment in biotech partnerships, precision medicine, and innovative drug development.
Stay informed with Chemxpert for trusted FDA recalls, pharmaceutical market intelligence, API supplier insights, CDMO developments, regulatory intelligence, biotech partnerships, and drug development updates.
📊 Book a Demo and discover how Chemxpert helps pharmaceutical professionals make faster, smarter business decisions.
🌐 Website: www.chemxpert.com
📧 Email: [email protected]
📞 Phone: 18004190155
📅 Date: 7 August 2026 | Week 2
Category
Contact the business
Website
Address
C-89, Sector/65
Noida
201301
Alerts
Be the first to know and let us send you an email when Chemxpert Database posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.